NCT00211991View on ClinicalTrials.gov

Evaluation of Consistency of StaphVAX Manufacturing Lots

PHASE3CompletedINTERVENTIONAL
Enrollment

354

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
Staphylococcal Infections
Interventions
BIOLOGICAL

S. aureus Type 5 & 8 Capsular Polysaccharide Conjugate

Trial Locations (1)

37232

Vanderbuilt University, Nashville

Sponsors
All Listed Sponsors
collaborator

Vanderbilt University

OTHER

lead

Nabi Biopharmaceuticals

INDUSTRY

NCT00211991 - Evaluation of Consistency of StaphVAX Manufacturing Lots | Biotech Hunter | Biotech Hunter